Female sexual arousal disorder (FSAD) is the inability to reach or maintain a sufficient physical response to sexual stimulation.
This study is evaluating the efficacy and safety of sildenafil cream in premenopausal patients with Female Sexual Arousal Disorder (FSAD).
Key eligibility criteria:
Premenopausal woman
Over 21 years of age
Other criteria may apply and will be reviewed during the phone screening process